Potential of antineoplastons in diseases of old age.
Burzynski
S R
SR
Burzynski Research Institute, Inc., Houston, Texas, USA.
D000368:Aged; D000375:Aging / Q000502:physiology*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D044482:Benzeneacetamides; D004338:Drug Combinations; D005973:Glutamine / Q000031:analogs & derivatives; D006131:Growth Inhibitors / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D010455:Peptides; D010648:Phenylacetates; D010881:Piperidones
D000970:Antineoplastic Agents; D044482:Benzeneacetamides; D004338:Drug Combinations; D006131:Growth Inhibitors; D010455:Peptides; D010648:Phenylacetates; D010881:Piperidones; C052090:antineoplaston A5; D005973:Glutamine; C092038:antineoplaston AS 2-1; C052089:antineoplaston A3; C052091:antineoplaston A10; C052088:antineoplaston A2